FDA Drug Shortages — Page 21
Browse FDA drug shortages by generic name, company, and status. RegDataLab tracks 1,695 drug shortages from official FDA sources, updated on an ongoing basis.
| Drug shortages | Details |
|---|---|
| Hydromorphone Hydrochloride Injection | Current — Fresenius Kabi USA, LLC |
| Dexamethasone Sodium Phosphate Injection | Current — Somerset Therapeutics, LLC |
| Dextrose Monohydrate 5% Injection | Current — Otsuka ICU Medical LLC |
| Lisdexamfetamine Dimesylate Capsule | Current — Alvogen |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Current — Granules Pharmaceuticals Inc. |
| Sodium Acetate Injection | Current — Milla Pharmaceuticals |
| Methylprednisolone Acetate Injection | Current — Sagent Pharmaceuticals |
| Fentanyl Citrate Injection | Current — Fresenius Kabi USA, LLC |
| Etomidate Injection | Current — Mylan Institutional, a Viatris Company |
| Insulin Degludec Injection | To Be Discontinued — Novo Nordisk, Inc. |
| Bumetanide Injection | Current — MSN Laboratories Private Limited |
| Lisdexamfetamine Dimesylate Capsule | Current — Elite Laboratories, Inc. |
| Liraglutide Injection | Current — Novo Nordisk, Inc. |
| Lisdexamfetamine Dimesylate Capsule | Current — Amneal Pharmaceuticals |
| Mirikizumab-mrkz Injection | To Be Discontinued — Eli Lilly and Co. |
| Fentanyl Citrate Injection | Current — Fresenius Kabi USA, LLC |
| Remifentanil Hydrochloride Injection | Current — Mylan Institutional, a Viatris Company |
| Dobutamine Hydrochloride Injection | Current — Hospira, Inc., a Pfizer Company |
| Amantadine Hydrochloride Tablet | To Be Discontinued — Upsher-Smith Laboratories, LLC |
| Bupivacaine Hydrochloride Injection | Current — Somerset Therapeutics, LLC |
| Fentanyl Citrate Injection | Current — Hikma Pharmaceuticals USA, Inc. |
| Atropine Sulfate Injection | Current — Accord Healthcare Inc. |
| Lisdexamfetamine Dimesylate Capsule | Current — Solco Healthcare US, LLC |
| Azithromycin Injection | To Be Discontinued — Pfizer Inc. |
| Peginterferon alfa-2a Injection | Resolved — pharmaand GmbH (pharma&) |
| Carboplatin Injection | Current — Gland Pharma Limited |
| Ropivacaine Hydrochloride Injection | Current — InfoRLife SA |
| Carboplatin Injection | Current — Teva Pharmaceuticals USA, Inc. |
| Dexmedetomidine Hydrochloride Injection | Current — Hikma Pharmaceuticals USA, Inc. |
| Clonazepam Tablet | Current — Rubicon Research Private Limited |
| Dopamine Hydrochloride Injection | Current — Baxter Healthcare |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Current — Alvogen |
| Clonazepam Tablet | Current — Rubicon Research Private Limited |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | Current — Sunrise Pharmaceutical, Inc. |
| Heparin Sodium Injection | Current — B. Braun Medical Inc. |
| Dextrose Monohydrate 5% Injection | Current — Otsuka ICU Medical LLC |
| Lisdexamfetamine Dimesylate Capsule | Current — Hikma Pharmaceuticals USA, Inc. |
| Methotrexate Injection | To Be Discontinued — Assertio Specialty Pharmaceuticals, LLC |
| Clonazepam Tablet | Current — Teva Pharmaceuticals USA, Inc. |
| Fentanyl Citrate Injection | Current — Hospira, Inc., a Pfizer Company |
| Levothyroxine Sodium Tablet | To Be Discontinued — EMD Serono, Inc. |
| Clonazepam Tablet | Current — Aurobindo Pharma USA |
| Lidocaine Hydrochloride Injection | Current — Fresenius Kabi USA, LLC |
| Epinephrine Injection | To Be Discontinued — Hospira, Inc., a Pfizer Company |
| Methylprednisolone Acetate Injection | Current — Par Health, USA LLC |
| Clindamycin Phosphate Injection | To Be Discontinued — Pfizer Inc. |
| Remifentanil Hydrochloride Injection | Current — Fresenius Kabi USA, LLC |
| Ampicillin Sodium Injection | To Be Discontinued — Sandoz Inc. |
| Hydroxocobalamin Injection | Current — BTG International Inc. |
| Guanfacine Hydrochloride Tablet, Extended Release | To Be Discontinued — Actavis Pharma, Inc. |